OPCH — Option Care Health, Inc. Stock Price, Chart & AI Report

Positive Jan 14, 2026 • 00:09 UTC The Motley Fool • Eric Volkman

Why Option Care Health Stock Zoomed 8% Higher on Tuesday

Option Care Health (OPCH) stock surged 8% on Tuesday following the announcement of preliminary Q4 2025 financial results. The company reported net sales of $1.46-$1.47 billion (up from $1.35 billion year-over-year) and non-GAAP net income of $73.8-$79 million ($0.46-$0.49 per share). Additionally, the company doubled its share repurchase authorization to $1 billion, demonstrating confidence in its business outlook.

OPCH preliminary earnings revenue growth share buyback healthcare Q4 2025 results

Sentiment note

The company demonstrated strong year-over-year revenue growth (8%+ increase), maintained profitability with non-GAAP net income comparable to prior year, and doubled its share repurchase authorization to $1 billion, signaling management confidence in the business and commitment to shareholder returns.

Positive Dec 12, 2025 • 12:00 UTC GlobeNewswire Inc. • Stephen Shulstein

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

Option Care Health, the largest independent home and alternate site infusion services provider, will present at the J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026.

OPCH healthcare infusion services investor conference home care

Sentiment note

Company is highlighting its national leadership, scale, and participation in a prominent healthcare investor conference, indicating confidence and growth potential

Positive Jul 30, 2025 • 11:00 UTC GlobeNewswire Inc. • Option Care Health

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

Option Care Health reported Q2 2025 financial results with net revenue of $1.42 billion, up 15.4% year-over-year. The company showed resilience in a dynamic marketplace, with adjusted diluted earnings per share of $0.41, up 10.8% from the previous year.

OPCH home infusion healthcare services financial results earnings report

Sentiment note

The company demonstrated revenue growth, increased earnings per share, and maintained a positive outlook with updated full-year financial guidance. The CEO's commentary suggests confidence in the company's performance and strategic execution.

Positive Feb 26, 2025 • 12:00 UTC GlobeNewswire Inc. • N/A

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024

Option Care Health, the largest independent provider of home and alternate site infusion services, reported strong financial results for the fourth quarter and full year 2024, with revenue growth and improved profitability. The company provided guidance for 2025, expecting continued growth and profitability.

OPCH Option Care Health home infusion services financial results guidance

Sentiment note

The company reported strong financial results, including revenue growth, improved profitability, and provided positive guidance for 2025, indicating a healthy and growing business.

Neutral Sep 17, 2024 • 12:00 UTC GlobeNewswire Inc. • N/A

AnewHealth Appoints Chief Growth Officer and Executive Vice President of Strategic Partnerships

AnewHealth, a pharmacy care management provider, has appointed Roman Fry as Chief Growth Officer and Joy Holman as Executive Vice President of Strategic Partnerships. These new hires will help the company expand its reach and reinvent pharmacy care for people with complex, chronic medical needs.

OPCH AnewHealth pharmacy care management complex chronic medical needs leadership team strategic growth

Sentiment note

The article mentions that Roman Fry previously held a leadership role at Option Care Health, but does not provide any additional information about the company, so a neutral sentiment is assigned.

Positive Jul 16, 2024 • 09:13 UTC Investing.com • Emilio Ghigini

JMP Securities bullish on Option Care Health stock Outperform amid market expansion - Investing.com

JMP Securities initiated coverage on Option Care Health (OPCH) with a Market Outperform rating and a price target of $36, citing the company's extensive national presence, comprehensive range of therapies, and robust commercial infrastructure as key factors for its positive outlook.

OPCH Option Care Health home infusion services market expansion

Sentiment note

JMP Securities is bullish on the stock, citing the company's strong market position, comprehensive service offerings, and commercial capabilities as drivers for potential growth and market share gains.

Positive Jul 8, 2024 • 20:07 UTC GlobeNewswire Inc. • N/A

Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call - GlobeNewswire

Option Care Health, the largest independent provider of home and alternate site infusion services, will release its Q2 2024 results on July 31, 2024 and host a conference call to discuss the results.

OPCH Option Care Health earnings release conference call

Sentiment note

The article announces the company's upcoming earnings release and conference call, indicating the company is performing well and providing updates to investors.

Unknown Jun 11, 2024 • 09:26 UTC Zacks Investment Research • Zacks Equity Research

Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol

J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.

APH JILL OPCH

Unknown Jun 10, 2024 • 11:56 UTC Zacks Investment Research • Santanu Roy

3 Stocks Backed by High Efficiency to Boost Portfolio Returns

Invest in stocks of J.Jill (JILL), Option Care Health (OPCH) and Amphenol (APH) to tap their high-efficiency levels.

APH JILL OPCH

Unknown Jun 10, 2024 • 09:49 UTC Zacks Investment Research • Zacks Equity Research

New Strong Buy Stocks for June 10th

NEM, ODP, IMMR, WSM and OPCH have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2024.

ODP NEM WSM IMMR

Unknown Jun 7, 2024 • 13:33 UTC Zacks Investment Research • Moumi Mondal

Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon

Investing in beaten-down stocks like OPCH, LNTH and HOLX can be profitable for investors in the long term.

HOLX LNTH OPCH

Unknown Jun 3, 2024 • 16:00 UTC Zacks Investment Research • Zacks Equity Research

Option Care (OPCH) Upgraded to Strong Buy: Here's Why

Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

OPCH